Aptose Biosciences Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Aptose Biosciences Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2017 to Q2 2024.
  • Aptose Biosciences Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $93K, a 71.2% decline year-over-year.
  • Aptose Biosciences Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $619K, a 55.6% decline year-over-year.
  • Aptose Biosciences Inc. annual Nonoperating Income (Expense) for 2023 was $1.15M, a 47.5% increase from 2022.
  • Aptose Biosciences Inc. annual Nonoperating Income (Expense) for 2022 was $779K, a 738% increase from 2021.
  • Aptose Biosciences Inc. annual Nonoperating Income (Expense) for 2021 was $93K, a 82.5% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $619K $93K -$230K -71.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $849K $120K -$300K -71.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.15M $172K -$231K -57.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $1.38M $234K -$15K -6.02% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.4M $323K +$215K +199% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.18M $420K +$401K +2111% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $779K $403K +$379K +1579% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $400K $249K +$223K +858% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $177K $108K +$90K +500% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $87K $19K -$6K -24% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $93K $24K -$22K -47.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 $115K $26K -$19K -42.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $134K $18K -$113K -86.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $247K $25K -$283K -91.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $530K $46K -$129K -73.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 $659K $45K -$138K -75.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $797K $131K +$3K +2.34% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $794K $308K +$214K +228% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $580K $175K +$111K +173% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-23
Q3 2019 $469K $183K +$103K +129% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $366K $128K +$61K +91% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $305K $94K +$66K +236% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $239K $64K +$23K +56.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 $216K $80K +$11K +15.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $205K $67K +$27K +67.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $178K $28K -$5K -15.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $183K $41K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 $69K Jul 1, 2017 Sep 30, 2017 8-K 2019-03-12
Q2 2017 $40K Apr 1, 2017 Jun 30, 2017 8-K 2019-03-12
Q1 2017 $33K Jan 1, 2017 Mar 31, 2017 8-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.